Tag: nitrosamines

Addressing Unassessed Raw Material Changes Post-Approval: An Actionable CAPA Playbook In pharmaceutical manufacturing, the integrity of raw materials is paramount and directly impacts product quality. When a raw material change…

How to Address Supplier Change Evaluation Gaps in Routine Operations In the fast-paced world of pharmaceutical manufacturing, unforeseen supplier changes can lead to significant compliance and quality issues. Failing to…

Addressing Uncommunicated Specification Changes During Post-Approval Reviews to Prevent Batch Rejections and Recalls In the highly regulated world of pharmaceutical manufacturing, the communication of specification changes during post-approval change reviews…

Understanding the Impacts of Supplier Changes in Pharmaceutical Manufacturing In an ever-evolving pharmaceutical landscape, the transition to new raw material suppliers is both necessary and fraught with challenges. Failing to…

Effective Playbook for Managing Unassessed Raw Material Changes During Routine Operations In the complex landscape of pharmaceutical manufacturing, the integrity of raw materials is paramount. Instances where a raw material…

Underestimating Change Impact During Supplier Transition: Key Questions for Inspectors In the pharmaceutical industry, changes in raw material suppliers can have profound implications for product quality and patient safety; however,…

Evaluating Supplier Changes in Deviation Investigations: A Practical Playbook In the dynamic landscape of pharmaceutical manufacturing, changes in raw material suppliers can lead to significant quality challenges. When deviations occur,…

Preventing Batch Rejection and Recalls from Supplier Change Evaluation Oversights In the competitive landscape of pharmaceutical manufacturing, oversight regarding raw materials can lead to significant operational challenges, such as product…

Proactive Strategies for Managing Raw Material Change During Regulatory Inspections The pharmaceutical manufacturing landscape is fraught with regulatory challenges, particularly around the management of raw materials. A raw material change…

Addressing Documentation Gaps in Change Control During Deviation Investigations In the pharmaceutical manufacturing environment, the integrity of raw material change control is paramount. A failure in documentation can lead to…

How to Address Uncommunicated Specification Changes During Deviation Investigations In the highly regulated environment of pharmaceutical manufacturing, the failure to communicate changes in raw material specifications can severely impact product…

Managing Unapproved Material Substitution during Post-Approval Change Reviews In the pharmaceutical manufacturing landscape, the integrity of raw materials is paramount for compliance and product quality. Unapproved material substitutions can lead…